精确的向黑色素瘤疗法通过cuproptosis/chemodynamic和化疗:一个工程MCHS-CuMOF纳米输送系统
Yixun Zhang1, Wenjie Xie2, Jinchuang Li2
1Department of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Biomaterials advances
|February 21, 2025
概括
研究人员确定FDX1是黑色素瘤cuproptosis的一个关键基因. 一种名为ACM@MCHS-CuMOF@Dox的新型纳米药物针对这种途径,显示出先进黑色素瘤治疗的前景.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
背景情况:
- 黑色素瘤由于耐药性和高死亡率而存在重大治疗挑战.
- Cuproptosis 是一种依赖铜的细胞死亡途径,成为黑色素瘤干预的新目标.
研究的目的:
- 通过机器学习识别黑色素瘤cuproptosis中的关键基因.
- 开发和评估一种用于利用cuproptosis进行向黑色素瘤治疗的新型纳米药物.
主要方法:
- 集成机器学习与基因组数据,以精确定位FDX1在cuproptosis路径.
- 工程ACM@MCHS-CuMOF@Dox纳米医药与生物仿真细胞膜涂层.
- 进行了体外研究,以评估细胞毒性,迁移,侵袭抑制和机械途径.
主要成果:
- 鉴定出FDX1是黑色素瘤cuproptosis中一个关键基因.
- ACM@MCHS-CuMOF@Dox证明了对黑色素瘤细胞增殖,迁移和入侵的优越抑制.
- 纳米药物通过FDX1降低调节诱导了亡和亡,增加了氧化应激.
结论:
- 将机器学习用于目标识别与先进的纳米医学相结合,为黑色素瘤治疗提供了一个强有力的策略.
- 开发的纳米医药显示了精确黑色素瘤治疗和个性化癌症护理的巨大潜力.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


